Murray, S <br/><br/>
TB Alliance regimen development for multidrug-resistant tuberculosis.  [electronic resource] 

 -  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease  12 2016 
 - 38-41 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1815-7920 
<br/><br/><label>Standard No.: </label>10.5588/ijtld.16.0069  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antitubercular Agents--therapeutic use<br/>Clinical Protocols<br/>Diarylquinolines--therapeutic use<br/>Dose-Response Relationship, Drug<br/>Ethambutol--therapeutic use<br/>Extensively Drug-Resistant Tuberculosis--drug therapy<br/>Fluoroquinolones--therapeutic use<br/>Humans<br/>Isoniazid--therapeutic use<br/>Linezolid--therapeutic use<br/>Moxifloxacin<br/>Nitroimidazoles--therapeutic use<br/>Pyrazinamide--therapeutic use<br/>Randomized Controlled Trials as Topic<br/>Research Design<br/>Rifampin--therapeutic use<br/>Tuberculosis, Multidrug-Resistant--drug therapy